Sentence examples for incremental cost will be from inspiring English sources

The incremental cost will be based on software, training and other costs incurred with transitioning practices to using HealthTracker.

The incremental cost will be compared to the incremental benefits of treatment in terms of a clinically significant improvement in pain, a clinically significant improvement in function, and the difference in quality adjusted life years (QALYs).

This incremental cost will be weighed up against the incremental benefit in terms of the incremental CKD cases detected by screening compared with routine diagnosis over the initial 2-year period that the entire screened cohort will run.

In each case the incremental cost will be compared to the incremental benefits of treatment in terms of a clinically significant improvement in pain, a clinically significant improvement in function, and the difference in quality adjusted life years (QALYs).

For example, experimental research in Lusaka, Zambia has shown that if the rate of MDI <70 due to birth asphyxia is reduced from 7 to 3.5%, the <span class="lh">incremental cost will be around $8.50 per DALY ($22,000 ÷[3.5/1000 absolute risk reduction × 2000 survivors of asphyxia enrolled per year × 37 years life expectancy]).

The incremental costs will be US$280 million for preventive, US$33 million for vaccines, and US$50 million for HIV interventions.

For every patient and study period, the mean incremental costs will be calculated, and, using double-sided bootstrapping, 95% confidence intervals (95%CI) will be estimated.

To allow a full understanding of cost-effectiveness and add value to the analysis, two different ways of measuring incremental costs will be compared; a time/material-based cost and the current cost to the NHS.

For calculation of the ICER, mean incremental policy costs will be divided by the mean incremental QALYs.

Incremental cost-effectiveness will be expressed in terms of incremental costs per QALY gained.

In a cost-utility analysis, with QALYs calculated from average life expectancy and utilities for severe neonatal morbidity, the incremental cost-effectiveness will be expressed as costs per QALY gained.